510(k) K073014

INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARIN by Autogenomics, Incorporated — Product Code ODW

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 23, 2008
Date Received
October 25, 2007
Clearance Type
Abbreviated
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Device Class
Class II
Regulation Number
862.3360
Review Panel
TX
Submission Type

An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized by the CYP2C9 gene product.